9-3228838-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001282116.2(RFX3):c.2011+9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00844 in 1,602,248 control chromosomes in the GnomAD database, including 72 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0062 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0087 ( 70 hom. )
Consequence
RFX3
NM_001282116.2 intron
NM_001282116.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.278
Genes affected
RFX3 (HGNC:9984): (regulatory factor X3) This gene is a member of the regulatory factor X gene family, which encodes transcription factors that contain a highly-conserved winged helix DNA binding domain. The protein encoded by this gene is structurally related to regulatory factors X1, X2, X4, and X5. It is a transcriptional activator that can bind DNA as a monomer or as a heterodimer with other RFX family members. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-3228838-G-A is Benign according to our data. Variant chr9-3228838-G-A is described in ClinVar as [Benign]. Clinvar id is 778032.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 945 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RFX3 | NM_001282116.2 | c.2011+9C>T | intron_variant | ENST00000617270.5 | NP_001269045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RFX3 | ENST00000617270.5 | c.2011+9C>T | intron_variant | 2 | NM_001282116.2 | ENSP00000482598 | P1 | |||
RFX3 | ENST00000382004.7 | c.2011+9C>T | intron_variant | 1 | ENSP00000371434 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00622 AC: 945AN: 151960Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
945
AN:
151960
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00596 AC: 1441AN: 241582Hom.: 8 AF XY: 0.00610 AC XY: 797AN XY: 130680
GnomAD3 exomes
AF:
AC:
1441
AN:
241582
Hom.:
AF XY:
AC XY:
797
AN XY:
130680
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00867 AC: 12577AN: 1450172Hom.: 70 Cov.: 29 AF XY: 0.00850 AC XY: 6135AN XY: 721482
GnomAD4 exome
AF:
AC:
12577
AN:
1450172
Hom.:
Cov.:
29
AF XY:
AC XY:
6135
AN XY:
721482
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00621 AC: 945AN: 152076Hom.: 2 Cov.: 33 AF XY: 0.00615 AC XY: 457AN XY: 74340
GnomAD4 genome
AF:
AC:
945
AN:
152076
Hom.:
Cov.:
33
AF XY:
AC XY:
457
AN XY:
74340
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 06, 2018 | - - |
RFX3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 07, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at